{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.44","upperLimit":"0.99","value":"0.66"},{"groupId":"OG001","lowerLimit":"1.04","upperLimit":"4.97","value":"2.45"},{"groupId":"OG002","lowerLimit":"2.31","upperLimit":"5.13","value":"3.41"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"114"},{"groupId":"OG001","value":"55"},{"groupId":"OG002","value":"107"}],"units":"Participants"}],"description":"The overall survival or survival time is defined as the time from registration to death due to any cause. The distribution of overall survival was estimated using the method of Kaplan-Meier.","dispersionType":"95% Confidence Interval","groups":[{"description":"Study 1.\n\nEverolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.\n\nEverolimus : Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.","id":"OG000","title":"Relapsed Aggressive Non-Hodgkin Lymphoma"},{"description":"Study 2.\n\nEverolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.\n\nEverolimus : Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.","id":"OG001","title":"Relapsed Indolent Non-Hodgkin Lymphoma"},{"description":"Study 3. Includes Hodgkin's lymphomas.\n\nEverolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.\n\nEverolimus : Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.","id":"OG002","title":"Uncommon Lymphomas"}],"paramType":"MEDIAN","populationDescription":"276 out of 277 were analyzed for response. One patient was excluded because of patient refusal before starting treatment.","reportingStatus":"POSTED","timeFrame":"5 years","title":"Overall Survival","type":"SECONDARY","unitOfMeasure":"years"}